These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18633341)

  • 1. Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases.
    Garibotto G; Russo R; Sofia A; Ferone D; Fiorini F; Cappelli V; Tarroni A; Gandolfo MT; Vigo E; Valli A; Arvigo M; Verzola D; Ravera G; Minuto F
    Kidney Int; 2008 Oct; 74(7):937-45. PubMed ID: 18633341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease.
    Verzola D; Procopio V; Sofia A; Villaggio B; Tarroni A; Bonanni A; Mannucci I; De Cian F; Gianetta E; Saffioti S; Garibotto G
    Kidney Int; 2011 Apr; 79(7):773-82. PubMed ID: 21228768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: effects of end-stage renal disease and microinflammatory state.
    Garibotto G; Sofia A; Procopio V; Villaggio B; Tarroni A; Di Martino M; Cappelli V; Gandolfo MT; Aloisi F; De Cian F; Sala MR; Verzola D
    Kidney Int; 2006 Jul; 70(2):384-90. PubMed ID: 16760905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation.
    Chen Y; Biada J; Sood S; Rabkin R
    Kidney Int; 2010 Jul; 78(1):89-95. PubMed ID: 20375991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.
    Garibotto G; Barreca A; Russo R; Sofia A; Araghi P; Cesarone A; Malaspina M; Fiorini F; Minuto F; Tizianello A
    J Clin Invest; 1997 Jan; 99(1):97-105. PubMed ID: 9011582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
    Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
    J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia.
    Greenstein J; Guest S; Tan JC; Tummala P; Busque S; Rabkin R
    J Ren Nutr; 2006 Apr; 16(2):141-9. PubMed ID: 16567271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.
    Axelsson J; Bergsten A; Qureshi AR; Heimbürger O; Bárány P; Lönnqvist F; Lindholm B; Nordfors L; Alvestrand A; Stenvinkel P
    Kidney Int; 2006 Feb; 69(3):596-604. PubMed ID: 16395259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.
    Carrero JJ; Witasp A; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Suliman ME; Anderstam B; Lindholm B; Nordfors L; Schalling M; Axelsson J
    Nephrol Dial Transplant; 2010 Mar; 25(3):901-6. PubMed ID: 19948877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress.
    Pupim LB; Himmelfarb J; McMonagle E; Shyr Y; Ikizler TA
    Kidney Int; 2004 Jun; 65(6):2371-9. PubMed ID: 15149350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
    Carrero JJ; Ortiz A; Qureshi AR; Martín-Ventura JL; Bárány P; Heimbürger O; Marrón B; Metry G; Snaedal S; Lindholm B; Egido J; Stenvinkel P; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):110-8. PubMed ID: 18945991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha and growth hormone resistance in patients with chronic liver disease.
    Picardi A; Gentilucci UV; Zardi EM; Caccavo D; Petitti T; Manfrini S; Pozzilli P; Afeltra A
    J Interferon Cytokine Res; 2003 May; 23(5):229-35. PubMed ID: 12804065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications.
    Fallahzadeh MK; Roozbeh J; Geramizadeh B; Namazi MR
    Nephrol Dial Transplant; 2011 Oct; 26(10):3338-44. PubMed ID: 21372257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study of free amino acid levels in serum and cerebral cortex in uremic rat].
    Kikuchi S; Matsumoto H; Yachi A
    No To Shinkei; 1984 Sep; 36(9):889-93. PubMed ID: 6508956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin and muscle metabolism in chronic uremia.
    Barazzoni R; Gortan Cappellari G; Zanetti M; Guarnieri G
    J Ren Nutr; 2012 Jan; 22(1):171-5. PubMed ID: 22200437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.